ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artificial Blood Substitute Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-11P9275
Home | Market Reports | Health| Pharmacy
Global Artificial Blood Substitute Market Size Status and Forecast 2022
BUY CHAPTERS

Global Artificial Blood Substitute Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-11P9275
Report
June 2025
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
Nuvox Pharma

Artificial Blood Substitute Market Size

In 2024, the global market size of Artificial Blood Substitute was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of 22.4% during the forecast period 2025-2031.

Artificial Blood Substitute Market

Artificial Blood Substitute Market

Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people"s demand for blood and make up for the current blood shortage.
Artificial blood substitutes are used as oxygen therapy agents for emergency resuscitation and disease treatment. They have very important practical significance in developing countries and field hospitals that lack blood and urgently need blood transfusion, lack refrigeration equipment, and even on the battlefield. At the same time they do have great potential in reducing the spread of infectious diseases and providing new options for religious people who refuse blood transfusions.
Despite the huge application prospects, these artificial blood products all face some common problems. In addition to the safety and efficacy to be verified by clinical trials, the current production scale still needs to be greatly increased, and the production cost needs to be greatly reduced to meet the future demand for artificial blood .

Report Scope

This report aims to provide a comprehensive presentation of the global market for Artificial Blood Substitute, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Blood Substitute.
The Artificial Blood Substitute market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Blood Substitute market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Blood Substitute companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Artificial Blood Substitute Market Report

Report Metric Details
Report Name Artificial Blood Substitute Market
CAGR 22.4%
Segment by Type
  • Perfluorocarbon-based Oxygen Carrier (PFBOC)
  • Hemoglobin-based Oxygen Carrier (HBOC)
Segment by Application
  • Military
  • Civil
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aurum Biosciences Ltd., HEMARINA SA, HbO2 Therapeutics, KaloCyte Inc., SpheriTech Ltd., NuvOx Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Artificial Blood Substitute in global and regional level.
  • Chapter 3: Detailed analysis of Artificial Blood Substitute company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Blood Substitute revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

Who are the main players in the Artificial Blood Substitute Market report?

Ans: The main players in the Artificial Blood Substitute Market are Aurum Biosciences Ltd., HEMARINA SA, HbO2 Therapeutics, KaloCyte Inc., SpheriTech Ltd., NuvOx Pharma

What are the Application segmentation covered in the Artificial Blood Substitute Market report?

Ans: The Applications covered in the Artificial Blood Substitute Market report are Military, Civil

What are the Type segmentation covered in the Artificial Blood Substitute Market report?

Ans: The Types covered in the Artificial Blood Substitute Market report are Perfluorocarbon-based Oxygen Carrier (PFBOC), Hemoglobin-based Oxygen Carrier (HBOC)

1 Study Coverage
1.1 Artificial Blood Substitute Product Introduction
1.2 Market by Type
1.2.1 Global Artificial Blood Substitute Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
1.2.3 Hemoglobin-based Oxygen Carrier (HBOC)
1.3 Market by Application
1.3.1 Global Artificial Blood Substitute Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Military
1.3.3 Civil
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Artificial Blood Substitute Market Size Estimates and Forecasts
2.2 Artificial Blood Substitute Market Size by Region: 2024 Versus 2031
2.2.1 Global Artificial Blood Substitute Revenue by Region: 2020-2025
2.2.2 Global Artificial Blood Substitute Revenue Forecast by Region (2026-2031)
2.2.3 Global Artificial Blood Substitute Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Artificial Blood Substitute Revenue by Type (2020-2031)
3.1.2 Global Artificial Blood Substitute Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Artificial Blood Substitute Revenue by Application (2020-2031)
3.2.2 Global Artificial Blood Substitute Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Perfluorocarbon-based Oxygen Carrier (PFBOC) of Artificial Blood Substitute Revenue Market Share by Application
3.3.2 Hemoglobin-based Oxygen Carrier (HBOC) of Artificial Blood Substitute Revenue Market Share by Application
4 Global Artificial Blood Substitute by Company
4.1 Global Artificial Blood Substitute Revenue by Company (2020-2025)
4.2 Global Artificial Blood Substitute Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Artificial Blood Substitute Companies around the World: Ranking by Revenue
4.3.2 Global Artificial Blood Substitute Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Artificial Blood Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Artificial Blood Substitute Companies Headquarters & Product Type
4.4.1 Global Artificial Blood Substitute Companies Headquarters
4.4.2 Date of International Companies Enter into Artificial Blood Substitute Market
4.4.3 Global Artificial Blood Substitute Companies Product & Service
4.4.4 Perfluorocarbon-based Oxygen Carrier (PFBOC) Revenue Market Share of Artificial Blood Substitute by Company
4.4.5 Hemoglobin-based Oxygen Carrier (HBOC) Revenue Market Share of Artificial Blood Substitute by Company
4.5 Global Artificial Blood Substitute Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Aurum Biosciences Ltd.
5.1.1 Aurum Biosciences Ltd. Corporation Information
5.1.2 Aurum Biosciences Ltd. Description, Business Overview
5.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Products Offered
5.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.1.5 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue by Product in 2024
5.1.6 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue by Application in 2024
5.1.7 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue by Geographic Area in 2024
5.1.8 Aurum Biosciences Ltd. Recent Developments
5.2 HEMARINA SA
5.2.1 HEMARINA SA Corporation Information
5.2.2 HEMARINA SA Description, Business Overview
5.2.3 HEMARINA SA Artificial Blood Substitute Products Offered
5.2.4 HEMARINA SA Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.2.5 HEMARINA SA Artificial Blood Substitute Revenue by Product in 2024
5.2.6 HEMARINA SA Artificial Blood Substitute Revenue by Application in 2024
5.2.7 HEMARINA SA Artificial Blood Substitute Revenue by Geographic Area in 2024
5.2.8 HEMARINA SA Recent Developments
5.3 HbO2 Therapeutics
5.3.1 HbO2 Therapeutics Corporation Information
5.3.2 HbO2 Therapeutics Description, Business Overview
5.3.3 HbO2 Therapeutics Artificial Blood Substitute Products Offered
5.3.4 HbO2 Therapeutics Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.3.5 HbO2 Therapeutics Artificial Blood Substitute Revenue by Product in 2024
5.3.6 HbO2 Therapeutics Artificial Blood Substitute Revenue by Application in 2024
5.3.7 HbO2 Therapeutics Artificial Blood Substitute Revenue by Geographic Area in 2024
5.3.8 HbO2 Therapeutics Recent Developments
5.4 KaloCyte Inc.
5.4.1 KaloCyte Inc. Corporation Information
5.4.2 KaloCyte Inc. Description, Business Overview
5.4.3 KaloCyte Inc. Artificial Blood Substitute Products Offered
5.4.4 KaloCyte Inc. Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.4.5 KaloCyte Inc. Artificial Blood Substitute Revenue by Product in 2024
5.4.6 KaloCyte Inc. Artificial Blood Substitute Revenue by Application in 2024
5.4.7 KaloCyte Inc. Artificial Blood Substitute Revenue by Geographic Area in 2024
5.4.8 KaloCyte Inc. Recent Developments
5.5 SpheriTech Ltd.
5.5.1 SpheriTech Ltd. Corporation Information
5.5.2 SpheriTech Ltd. Description, Business Overview
5.5.3 SpheriTech Ltd. Artificial Blood Substitute Products Offered
5.5.4 SpheriTech Ltd. Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.5.5 SpheriTech Ltd. Artificial Blood Substitute Revenue by Product in 2024
5.5.6 SpheriTech Ltd. Artificial Blood Substitute Revenue by Application in 2024
5.5.7 SpheriTech Ltd. Artificial Blood Substitute Revenue by Geographic Area in 2024
5.5.8 SpheriTech Ltd. Recent Developments
5.6 NuvOx Pharma
5.6.1 NuvOx Pharma Corporation Information
5.6.2 NuvOx Pharma Description, Business Overview
5.6.3 NuvOx Pharma Artificial Blood Substitute Products Offered
5.6.4 NuvOx Pharma Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.6.5 NuvOx Pharma Artificial Blood Substitute Revenue by Product in 2024
5.6.6 NuvOx Pharma Artificial Blood Substitute Revenue by Application in 2024
5.6.7 NuvOx Pharma Artificial Blood Substitute Revenue by Geographic Area in 2024
5.6.8 NuvOx Pharma Recent Developments
6 North America
6.1 North America Artificial Blood Substitute Market Size YoY Growth 2020-2031
6.2 North America Artificial Blood Substitute Market Facts & Figures by Country (2020-2031)
6.3 North America Artificial Blood Substitute Revenue by Type (2020-2025)
6.4 North America Artificial Blood Substitute Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Artificial Blood Substitute Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Artificial Blood Substitute Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Artificial Blood Substitute Revenue by Type (2020-2025)
7.4 Asia-Pacific Artificial Blood Substitute Revenue by Application (2020-2025)
8 Europe
8.1 Europe Artificial Blood Substitute Market Size YoY Growth 2020-2031
8.2 Europe Artificial Blood Substitute Market Facts & Figures by Country (2020-2031)
8.3 Europe Artificial Blood Substitute Revenue by Type (2020-2025)
8.4 Europe Artificial Blood Substitute Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Artificial Blood Substitute Market Size YoY Growth 2020-2031
9.2 Latin America Artificial Blood Substitute Market Facts & Figures by Country (2020-2031)
9.3 Latin America Artificial Blood Substitute Revenue by Type (2020-2025)
9.4 Latin America Artificial Blood Substitute Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Artificial Blood Substitute Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Artificial Blood Substitute Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Artificial Blood Substitute Revenue by Type (2020-2025)
10.4 Middle East and Africa Artificial Blood Substitute Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Artificial Blood Substitute Supply Chain Analysis
11.2 Artificial Blood Substitute Key Raw Materials and Upstream Suppliers
11.3 Artificial Blood Substitute Clients Analysis
11.4 Artificial Blood Substitute Sales Channel and Sales Model Analysis
11.4.1 Artificial Blood Substitute Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Artificial Blood Substitute Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Artificial Blood Substitute Distributors
12 Artificial Blood Substitute Market Dynamics
12.1 Artificial Blood Substitute Industry Trends
12.2 Artificial Blood Substitute Market Drivers
12.3 Artificial Blood Substitute Market Challenges
12.4 Artificial Blood Substitute Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
Nuvox Pharma
List of Tables
 Table 1. Global Artificial Blood Substitute Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Artificial Blood Substitute Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Artificial Blood Substitute Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Artificial Blood Substitute Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Artificial Blood Substitute Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Artificial Blood Substitute Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Artificial Blood Substitute Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Artificial Blood Substitute Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Artificial Blood Substitute Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Artificial Blood Substitute Players by Revenue (US$ Million) in 2024
 Table 13. Global Artificial Blood Substitute Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Artificial Blood Substitute by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood Substitute as of 2024)
 Table 15. Global Artificial Blood Substitute Companies Headquarters
 Table 16. Date of International Companies Enter into Artificial Blood Substitute Market
 Table 17. Global Artificial Blood Substitute Companies Product & Service
 Table 18. Global Artificial Blood Substitute Mergers & Acquisitions, Expansion Plans
 Table 19. Aurum Biosciences Ltd. Corporation Information
 Table 20. Aurum Biosciences Ltd. Description and Business Overview
 Table 21. Aurum Biosciences Ltd. Artificial Blood Substitute Product
 Table 22. Aurum Biosciences Ltd. Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Aurum Biosciences Ltd. Revenue Proportion of Artificial Blood Substitute by Product in 2024
 Table 24. Aurum Biosciences Ltd. Revenue Proportion of Artificial Blood Substitute by Application in 2024
 Table 25. Aurum Biosciences Ltd. Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
 Table 26. Aurum Biosciences Ltd. Recent Developments
 Table 27. HEMARINA SA Corporation Information
 Table 28. HEMARINA SA Description and Business Overview
 Table 29. HEMARINA SA Artificial Blood Substitute Product
 Table 30. HEMARINA SA Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. HEMARINA SA Revenue Proportion of Artificial Blood Substitute by Product in 2024
 Table 32. HEMARINA SA Revenue Proportion of Artificial Blood Substitute by Application in 2024
 Table 33. HEMARINA SA Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
 Table 34. HEMARINA SA Recent Developments
 Table 35. HbO2 Therapeutics Corporation Information
 Table 36. HbO2 Therapeutics Description and Business Overview
 Table 37. HbO2 Therapeutics Artificial Blood Substitute Product
 Table 38. HbO2 Therapeutics Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. HbO2 Therapeutics Revenue Proportion of Artificial Blood Substitute by Product in 2024
 Table 40. HbO2 Therapeutics Revenue Proportion of Artificial Blood Substitute by Application in 2024
 Table 41. HbO2 Therapeutics Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
 Table 42. HbO2 Therapeutics Recent Developments
 Table 43. KaloCyte Inc. Corporation Information
 Table 44. KaloCyte Inc. Description and Business Overview
 Table 45. KaloCyte Inc. Artificial Blood Substitute Product
 Table 46. KaloCyte Inc. Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. KaloCyte Inc. Revenue Proportion of Artificial Blood Substitute by Product in 2024
 Table 48. KaloCyte Inc. Revenue Proportion of Artificial Blood Substitute by Application in 2024
 Table 49. KaloCyte Inc. Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
 Table 50. KaloCyte Inc. Recent Developments
 Table 51. SpheriTech Ltd. Corporation Information
 Table 52. SpheriTech Ltd. Description and Business Overview
 Table 53. SpheriTech Ltd. Artificial Blood Substitute Product
 Table 54. SpheriTech Ltd. Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. SpheriTech Ltd. Revenue Proportion of Artificial Blood Substitute by Product in 2024
 Table 56. SpheriTech Ltd. Revenue Proportion of Artificial Blood Substitute by Application in 2024
 Table 57. SpheriTech Ltd. Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
 Table 58. SpheriTech Ltd. Recent Developments
 Table 59. NuvOx Pharma Corporation Information
 Table 60. NuvOx Pharma Description and Business Overview
 Table 61. NuvOx Pharma Artificial Blood Substitute Product
 Table 62. NuvOx Pharma Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. NuvOx Pharma Revenue Proportion of Artificial Blood Substitute by Product in 2024
 Table 64. NuvOx Pharma Revenue Proportion of Artificial Blood Substitute by Application in 2024
 Table 65. NuvOx Pharma Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
 Table 66. NuvOx Pharma Recent Developments
 Table 67. North America Artificial Blood Substitute Revenue by Country (2020-2025) & (US$ Million)
 Table 68. North America Artificial Blood Substitute Revenue by Country (2026-2031) & (US$ Million)
 Table 69. North America Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
 Table 70. North America Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
 Table 71. Asia-Pacific Artificial Blood Substitute Revenue by Region (2020-2025) & (US$ Million)
 Table 72. Asia-Pacific Artificial Blood Substitute Revenue by Region (2026-2031) & (US$ Million)
 Table 73. Asia-Pacific Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
 Table 74. Asia-Pacific Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
 Table 75. Europe Artificial Blood Substitute Revenue by Country (2020-2025) & (US$ Million)
 Table 76. Europe Artificial Blood Substitute Revenue by Country (2026-2031) & (US$ Million)
 Table 77. Europe Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
 Table 78. Europe Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
 Table 79. Latin America Artificial Blood Substitute Revenue by Country (2020-2025) & (US$ Million)
 Table 80. Latin America Artificial Blood Substitute Revenue by Country (2026-2031) & (US$ Million)
 Table 81. Latin America Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
 Table 82. Latin America Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
 Table 83. Middle East and Africa Artificial Blood Substitute Revenue by Country (2020-2025) & (US$ Million)
 Table 84. Middle East and Africa Artificial Blood Substitute Revenue by Country (2026-2031) & (US$ Million)
 Table 85. Middle East and Africa Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
 Table 86. Middle East and Africa Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
 Table 87. Artificial Blood Substitute Key Raw Materials, Industry Status and Trend
 Table 88. Artificial Blood Substitute Key Raw Materials and Upstream Suppliers
 Table 89. Artificial Blood Substitute Clients Status and Trend
 Table 90. Artificial Blood Substitute Typical Clients
 Table 91. Artificial Blood Substitute Distributors
 Table 92. Artificial Blood Substitute Market Trends
 Table 93. Artificial Blood Substitute Market Drivers
 Table 94. Artificial Blood Substitute Market Challenges
 Table 95. Artificial Blood Substitute Market Restraints
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources


List of Figures
 Figure 1. Artificial Blood Substitute Product Picture
 Figure 2. Global Artificial Blood Substitute Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Artificial Blood Substitute Revenue Market Share by Type in 2024 & 2031
 Figure 4. Perfluorocarbon-based Oxygen Carrier (PFBOC) Product Picture
 Figure 5. Hemoglobin-based Oxygen Carrier (HBOC) Product Picture
 Figure 6. Global Artificial Blood Substitute Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Artificial Blood Substitute Revenue Market Share by Application in 2024 & 2031
 Figure 8. Military
 Figure 9. Civil
 Figure 10. Artificial Blood Substitute Report Years Considered
 Figure 11. Global Artificial Blood Substitute Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Artificial Blood Substitute Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Artificial Blood Substitute Market Size Market Share by Region: 2024 Versus 2031
 Figure 14. Global Artificial Blood Substitute Revenue Market Share by Region (2020-2031)
 Figure 15. Global Artificial Blood Substitute Revenue Market Share Forecast by Type (2020-2031)
 Figure 16. Global Artificial Blood Substitute Revenue Market Share Forecast by Application (2020-2031)
 Figure 17. Perfluorocarbon-based Oxygen Carrier (PFBOC) of Artificial Blood Substitute Revenue Market Share by Application, 2024 VS 2031
 Figure 18. Hemoglobin-based Oxygen Carrier (HBOC) of Artificial Blood Substitute Revenue Market Share by Application, 2024 VS 2031
 Figure 19. Artificial Blood Substitute Revenue Share by Company (2024)
 Figure 20. Artificial Blood Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Perfluorocarbon-based Oxygen Carrier (PFBOC) Revenue Proportion by Company in 2024
 Figure 22. Hemoglobin-based Oxygen Carrier (HBOC) Revenue Proportion by Company in 2024
 Figure 23. North America Artificial Blood Substitute Revenue 2020-2031 (US$ Million)
 Figure 24. North America Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
 Figure 25. North America Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
 Figure 26. Asia-Pacific Artificial Blood Substitute Revenue 2020-2031 (US$ Million)
 Figure 27. Asia-Pacific Artificial Blood Substitute Revenue Market Share by Region (2020-2031)
 Figure 28. Asia-Pacific Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
 Figure 29. Asia-Pacific Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
 Figure 30. Europe Artificial Blood Substitute Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 31. Europe Artificial Blood Substitute Revenue Market Share by Country (2020-2031)
 Figure 32. Europe Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
 Figure 33. Europe Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
 Figure 34. Latin America Artificial Blood Substitute Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 35. Latin America Artificial Blood Substitute Revenue Market Share by Country (2020-2031)
 Figure 36. Latin America Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
 Figure 37. Latin America Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
 Figure 38. Middle East and Africa Artificial Blood Substitute Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 39. Middle East and Africa Artificial Blood Substitute Revenue Market Share by Country (2020-2031)
 Figure 40. Middle East and Africa Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
 Figure 41. Middle East and Africa Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
 Figure 42. Artificial Blood Substitute Supply Chain (Upstream and Downstream Market)
 Figure 43. Global Production Market Share of Artificial Blood Substitute Raw Materials by Region in 2024
 Figure 44. Artificial Blood Substitute Distribution Channels
 Figure 45. Global Artificial Blood Substitute Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 46. Global Artificial Blood Substitute Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 47. Bottom-up and Top-down Approaches for This Report
 Figure 48. Data Triangulation
 Figure 49. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Artificial Blood Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Synthetic Blood Substitutes and Blood Product Market Research Report 2025
Global Artificial Blood Cells Market Research Report 2025
Synthetic Blood Substitutes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Substitute Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Blood Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Artificial Bone Substitute Market Research Report 2025
Global Artificial Skin Substitute Market Research Report 2025
Global Artificial Sweetener and Sugar Substitute Market Research Report 2024
Global Artificial Liver Market Research Report 2024
Global Artificial Kidney Market Research Report 2024
Global Artificial Leather Products Market Research Report 2024
Global Synthetic Artificial Blood Vessels Market Research Report 2025
Global Artificial Blood Vessel Replacement Market Research Report 2025
Global Artificial Blood Vessel Market Research Report 2025
Global Automotive PVC Artificial Leather Market Research Report 2025
Artificial Valve Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Vital Organs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Artificial Photosynthesis Market Research Report 2024
Global Blood Compatible Polymers Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions